프로톤 펌프 억제제(PPI) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)
Proton Pump Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1508451
리서치사:Transparency Market Research
발행일:2024년 05월
페이지 정보:영문 155 Pages
라이선스 & 가격 (부가세 별도)
한글목차
프로톤 펌프 억제제(PPI) 시장 - 조사 범위
TMR의 조사 보고서 "세계의 프로톤 펌프 억제제(PPI) 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회도 조사했습니다. 이 보고서는 2024년을 기준 연도, 2034년을 예측 연도로 하여 2018년부터 2034년까지 세계 프로톤 펌프 억제제(PPI) 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 프로톤 펌프 억제제(PPI) 시장의 연평균 성장률(CAGR%)도 제시합니다.
이 보고서는 광범위한 1차 조사, KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체와의 인터뷰, 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참조한 2차 조사를 통해 프로톤 펌프 억제제(PPI) 시장을 추론했습니다.
시장 현황
2023년 시장 규모
37억 달러
2034년 시장 규모
56억 달러
CAGR
4%
이 보고서는 세계 프로톤 펌프 억제제(PPI) 시장의 경쟁 환경을 조사했습니다. 세계 프로톤 펌프 억제제(PPI) 시장에서 활동하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 소개된 세계 프로톤 펌프 억제제(PPI) 시장 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약
제4장 시장 개요
서론
개요
시장 역학
세계 시장 분석과 예측, 2020-2034년
Porter의 Five Forces 분석
제5장 주요 인사이트
규제 시나리오
제품 승인/발매
파이프라인 분석
제6장 세계 시장 분석과 예측 : 약제 유형별
서론과 정의
주요 조사 결과/ 진전
시장 매출 예측 : 약제 유형별, 2020-2034년
Omeprazole
Pantoprazole
Esomeprazole
Lansoprazole
Rabeprazole
기타(Dexlansoprazole 등)
약제 유형별 시장의 매력
제7장 세계 시장 분석과 예측 : 적응증 유형별
서론과 정의
주요 조사 결과/ 진전
시장 매출 예측 : 적응증 유형별, 2020-2034년
위식도 역류증
소화성 궤양
적응증 유형별 시장의 매력
제8장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과/ 진전
시장 매출 예측 : 최종사용자별, 2020-2034년
병원 약국
소매 약국
온라인 약국
최종사용자별 시장의 매력
제9장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
국가/지역별 시장의 매력
제10장 북미 시장 분석과 예측
미국
캐나다
제11장 유럽 시장 분석과 예측
독일
영국
프랑스
이탈리아
스페인
기타 유럽
제12장 아시아태평양 시장 분석과 예측
중국
인도
일본
호주 및 뉴질랜드
기타 아시아태평양
제13장 라틴아메리카 시장 분석과 예측
브라질
멕시코
기타 라틴아메리카
제14장 중동 및 아프리카 시장 분석과 예측
GCC
남아프리카공화국
기타 중동 및 아프리카
제15장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
기업 개요
Pfizer
Teva Pharmaceutical Industries Ltd.
LUPIN Limited
Amneal Pharmaceuticals LLC
Zydus Cadila
Sun Pharmaceutical Industries Ltd.
Alembic Pharmaceuticals Limited
Sanofi S.A.
AstraZeneca
LSH
영문 목차
영문목차
Proton Pump Inhibitors (PPIs) Market - Scope of Report
TMR's report on the global proton pump inhibitors (PPIs) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global proton pump inhibitors (PPIs) market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global proton pump inhibitors (PPIs) market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the proton pump inhibitors (PPIs) market.
Market Snapshot
Market Value in 2023
US$ 3.7 Bn
Market Value in 2034
US$ 5.6 Bn
CAGR
4%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global proton pump inhibitors (PPIs) market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global proton pump inhibitors (PPIs) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global proton pump inhibitors (PPIs) market.
The report delves into the competitive landscape of the global proton pump inhibitors (PPIs) market. Key players operating in the global proton pump inhibitors (PPIs) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global proton pump inhibitors (PPIs) market profiled in this report.
Key Questions Answered in Global proton pump inhibitors (PPIs) Market Report:
What is the sales/revenue generated by proton pump inhibitors (PPIs) across all regions during the forecast period?
What are the opportunities in the global proton pump inhibitors (PPIs) market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Proton Pump Inhibitors (PPIs) Market - Research Objectives and Research Approach
The comprehensive report on the global proton pump inhibitors (PPIs) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global proton pump inhibitors (PPIs) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global proton pump inhibitors (PPIs) market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Proton Pump Inhibitors (PPIs) Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, 2020-2034
4.5. Porter's Five Force Analysis
5. Key Insights
5.1. Regulatory Scenario
5.2. Product Approval/Launches
5.3. Pipeline Analysis
6. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Drug Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Drug Type, 2020-2034
6.3.1. Omeprazole
6.3.2. Pantoprazole
6.3.3. Esomeprazole
6.3.4. Lansoprazole
6.3.5. Rabeprazole
6.3.6. Others (Dexlansoprazole, etc.)
6.4. Market Attractiveness By Drug Type
7. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Indication Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Indication Type, 2020-2034
7.3.1. Gastroesophageal Reflux Disease
7.3.2. Peptic Ulcers
7.4. Market Attractiveness By Indication Type
8. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020-2034
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness By End-user
9. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Proton Pump Inhibitors (PPIs) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Drug Type, 2020-2034
10.2.1. Omeprazole
10.2.2. Pantoprazole
10.2.3. Esomeprazole
10.2.4. Lansoprazole
10.2.5. Rabeprazole
10.2.6. Others (Dexlansoprazole, etc.)
10.3. Market Value Forecast By Indication Type, 2020-2034
10.3.1. Gastroesophageal Reflux Disease
10.3.2. Peptic Ulcers
10.4. Market Value Forecast By End-user, 2020-2034
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Market Value Forecast By, 2020-2034
10.6. Market Value Forecast By Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Drug Type
10.7.2. By Indication Type
10.7.3. By End-user
10.7.4. By Country
11. Europe Proton Pump Inhibitors (PPIs) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Drug Type, 2020-2034
11.2.1. Omeprazole
11.2.2. Pantoprazole
11.2.3. Esomeprazole
11.2.4. Lansoprazole
11.2.5. Rabeprazole
11.2.6. Others (Dexlansoprazole, etc.)
11.3. Market Value Forecast By Indication Type, 2020-2034
11.3.1. Gastroesophageal Reflux Disease
11.3.2. Peptic Ulcers
11.4. Market Value Forecast By End-user, 2020-2034
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Market Value Forecast By, 2020-2034
11.6. Market Value Forecast By Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Drug Type
11.7.2. By Indication Type
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Proton Pump Inhibitors (PPIs) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Drug Type, 2020-2034
12.2.1. Omeprazole
12.2.2. Pantoprazole
12.2.3. Esomeprazole
12.2.4. Lansoprazole
12.2.5. Rabeprazole
12.2.6. Others (Dexlansoprazole, etc.)
12.3. Market Value Forecast By Indication Type, 2020-2034
12.3.1. Gastroesophageal Reflux Disease
12.3.2. Peptic Ulcers
12.4. Market Value Forecast By End-user, 2020-2034
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Market Value Forecast By, 2020-2034
12.6. Market Value Forecast By Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. India
12.6.3. Japan
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Drug Type
12.7.2. By Indication Type
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Proton Pump Inhibitors (PPIs) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Drug Type, 2020-2034
13.2.1. Omeprazole
13.2.2. Pantoprazole
13.2.3. Esomeprazole
13.2.4. Lansoprazole
13.2.5. Rabeprazole
13.2.6. Others (Dexlansoprazole, etc.)
13.3. Market Value Forecast By Indication Type, 2020-2034
13.3.1. Gastroesophageal Reflux Disease
13.3.2. Peptic Ulcers
13.4. Market Value Forecast By End-user, 2020-2034
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Market Value Forecast By, 2020-2034
13.6. Market Value Forecast By Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Drug Type
13.7.2. By Indication Type
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Proton Pump Inhibitors (PPIs) Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Drug Type, 2020-2034
14.2.1. Omeprazole
14.2.2. Pantoprazole
14.2.3. Esomeprazole
14.2.4. Lansoprazole
14.2.5. Rabeprazole
14.2.6. Others (Dexlansoprazole, etc.)
14.3. Market Value Forecast By Indication Type, 2020-2034
14.3.1. Gastroesophageal Reflux Disease
14.3.2. Peptic Ulcers
14.4. Market Value Forecast By End-user, 2020-2034
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Market Value Forecast By, 2020-2034
14.6. Market Value Forecast By Country, 2020-2034
14.6.1. GCC
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Drug Type
14.7.2. By Indication Type
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
